FDA 510(k) clearance · back to tracker

NxStage System One with NxView

Fresenius Medical Care Renal Therapies Group, LLC cleared K252377 on 2026-05-15, decision: substantially equivalent

K-number

K252377

Sponsor

Fresenius Medical Care Renal Therapies Group, LLC

Device

NxStage System One with NxView

Class

Class II

Decision

Substantially Equivalent

Decision date

2026-05-15

Product code

KDI

Advisory committee

Gastroenterology, Urology

Medical specialty

Gastroenterology, Urology

Regulation number

876.5860

Official FDA record

Open K252377on accessdata.fda.gov →

FDA's authoritative 510(k) summary page. Includes the decision letter, predicate references, and downloadable substantial-equivalence determination.

openFDA JSON

Raw record →

Machine-readable JSON. Useful for cross-referencing classification, product code, and advisory committee fields.

Use this as a predicate

Drop K252377 into Compass and start a substantial-equivalence draft.

Compass pulls the predicate's intended use, technological characteristics, and performance data, maps them against your device, and produces a draft SE table aligned to FDA's 510(k) program guidance.

Try the sandbox

Source

Public 510(k) database, U.S. Food and Drug Administration, accessed via openFDA. Page refreshed weekly.